Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan version 2.0 human immunodeficiency virus type 1 assay.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Accurate HIV viral load measurement in primary health care settings using the cobas® plasma separation card.PloS one · 2020
   Article
2. Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.PLoS biology · 2017
   Article
3. Sensitivity and specificity of dried blood spots for HIV-1 viral load quantification: A laboratory assessment of 3 commercial assays.Medicine · 2016
   Article
4. Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
   Article
5. Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification.The Kaohsiung journal of medical sciences · 2015
   Article
6. Detection of Acute HIV-1 Infection by RT-LAMP.PloS one · 2015
   Article
7. Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (<1,000 copies/milliliter): comparison with clinical samples and NIBSC working reagent for nucleic acid testing assays.Journal of clinical microbiology · 2014
   Article
8. Comparison of the COBAS/Ampliprep Taqman and Amplicor HIV-1 monitor tests in Lagos, Nigeria.African journal of laboratory medicine · 2013
   Article
9. Use of a prequalification panel for rapid scale-up of high-throughput HIV viral load testing.Journal of clinical microbiology · 2012
   Article
10. Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age.Journal of clinical microbiology · 2012
    Article
11. Current practices in laboratory monitoring of HIV infection.The Indian journal of medical research · 2011
    Review
12. Abbott RealTime HIV-1 m2000rt viral load testing: manual extraction versus the automated m2000sp extraction.Journal of virological methods · 2011
    Article
13. Comparative evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay.Journal of clinical microbiology · 2011
    Article
14. HIV-1 load comparison using four commercial real-time assays.Journal of clinical microbiology · 2011
    Article
15. Potential influence of more-sensitive HIV-1 load detection by the new Roche Cobas AmpliPrep/Cobas TaqMan version 2.0 assay on clinical management of HIV-positive pregnant women.Journal of clinical microbiology · 2010
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as